2019 Webinars

Currently, there are no vaccines approved for use in the prevention of Zika. In this webinar, we discuss the development of several novel Zika virus-like particle (Zika-VLP)–based vaccine candidates and will provide data demonstrating their ability to induce a strong immune response and provide a high level of protection against Zika virus in murine animal models.

In this webinar an ATCC expert taps into ATCC’s vast experience and shares the best practices for culturing cells that ensure optimal results and performance. The information delivered covers all aspects of successful cell culture, including culture initiation, expansion, authentication, and cryopreservation.

Epithelial-to-mesenchymal transition (EMT) and its reverse (MET) are physiological mechanisms implicated in cancer metastasis. Watch this webinar to learn how CRISPR/Cas9 genome-editing technology was applied to develop a number of RFP- or GFP-tagged reporter cell lines to study EMT and MET phenomena.

Watch the presentation to learn how CRISPR/Cas9 genome-editing technology was used to introduce a specific point mutation that confers drug resistance into A375 melanoma line, and consider data indicating that this isogenic cell line is resistant to MEK and BRAF inhibitors and sensitive to therapies targeting upstream and downstream elements of the Ras/Raf-MAPK signaling pathway.

Developing cell-based assays can be problematic; the cells must be physiologically relevant for the assay to be predictive, yet sufficiently abundant to be included in the assay without introducing interexperimental variability. Watch this webinar to learn how hTERT-immortalized primary cells exhibit the growth characteristics of cell lines while providing the physiological attributes of primary cells.

Differentiated induced pluripotent stem cell (iPSC)-derived cells fulfill the need for a consistent source of cells and physiological relevance. This webinar provides data demonstrating how differentiated iPSC-derived cells can be incorporated into immunoassays or further differentiated into cell types such as osteocytes, chondrocytes, and adipocytes.

With the undeniable variability in next-generation sequencing data, it is essential that standards are incorporated at each stage of the workflow. In this webinar, we provide an overview on the current challenges in microbiome research and demonstrate the application of mock microbial communities in assay development and standardization.

Watch this webinar to hear an overview of exosomes from various well-characterized ATCC cell lines and data indicating that these extracellular vesicles can be used as reference materials in biological research and assay development.

As part of our commitment to advancing authentication in life science research, ATCC has implemented a robust NGS and genome assembly workflow to enrich the characterization of biological materials in our collection. In this webinar, we detail the standardized process and quality control criteria that we use to produce reference-quality genomes.

Reliable controls are a critical component in the development of molecular-based assays. In this webinar, we cover ATCC’s growing offering of quantitative genomic and synthetic molecular standards and we provide application data demonstrating the potential use of these products in diagnostic assay development.

Tick-borne diseases (TBD) among humans are on the rise in the United States as urbanization along previously unpopulated areas continues. In this webinar, we will provide an overview of TBD epidemiology, the current status of diagnostic methods, and resources available from ATCC that advance TBD research priorities.

There is an unmet need for preclinical cancer models that better reflect the genotype and phenotype across the spectrum of cancer found in the patient population. Watch this webinar to hear about the wide variety of patient-derived in vitro cancer models ATCC offers in collaboration with HCMI, including organoids, neurospheres, and conditionally reprogrammed cells.